Chemical Component Summary | |
---|---|
Name | Ridinilazole |
Synonyms | 2-pyridin-4-yl-5-(2-pyridin-4-yl-1H-benzimidazol-5-yl)-1H-benzimidazole |
Identifiers | 2-pyridin-4-yl-5-(2-pyridin-4-yl-1~{H}-benzimidazol-5-yl)-1~{H}-benzimidazole |
Formula | C24 H16 N6 |
Molecular Weight | 388.424 |
Type | NON-POLYMER |
Isomeric SMILES | c1cc2c(cc1c3ccc4c(c3)nc([nH]4)c5ccncc5)nc([nH]2)c6ccncc6 |
InChI | InChI=1S/C24H16N6/c1-3-19-21(29-23(27-19)15-5-9-25-10-6-15)13-17(1)18-2-4-20-22(14-18)30-24(28-20)16-7-11-26-12-8-16/h1-14H,(H,27,29)(H,28,30) |
InChIKey | UHQFBTAJFNVZIV-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 46 |
Chiral Atom Count | 0 |
Bond Count | 51 |
Aromatic Bond Count | 32 |
Drug Info: DrugBank
DrugBank ID | DB15308 |
---|---|
Name | Ridinilazole |
Groups | investigational |
Description | Ridinilazole is under investigation in clinical trial NCT02092935 (A Study of SMT19969 Compared With Vancomycin for the Treatment of Clostridium Difficile-Associated Diarrhoea (CDAD)). |
Synonyms | Ridinilazole |
Categories |
|
CAS number | 308362-25-6 |
Related Resource References
Resource Name | Reference |
---|---|
PubChem | 16659285 |
ChEMBL | CHEMBL3753858 |